SuperworthRoyalty Pharma market cap RPRX
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Oct 23, 2026
- $36.7B
- Highest close in our data
- $36.8B
- Sep 2026
Royalty Pharma is worth $36.7B at the close on Oct 23, 2026, at $63.86 a share.
That is up 69% over the last year and up 53% over five years.
Its highest close in our data was $36.8B in Sep 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $36.7B | $22.4B | $36.8B | +62% |
| 2025 | $22.6B | $15.2B | $23.1B | +50% |
| 2024 | $15B | $14.6B | $18.5B | −10% |
| 2023 | $16.8B | $15.8B | $23.9B | −30% |
| 2022 | $24B | $23.2B | $26.8B | −1% |
| 2021 | $24.2B | $18.2B | $28.5B | +25% |
| 2020 | $19.4B | $13.4B | $19.4B | n/a |
Against its peers
Companies in Healthcare nearest Royalty Pharma's size, closest first, today.
| Company | Market cap |
|---|---|
| RPRXRoyalty Pharma | $36.7B |
| RMDResMed | $36.5B |
| BIIBBiogen | $37B |
| CNCCentene | $34.7B |
| ZTSZoetis | $33.5B |
| MTDMettler-Toledo International | $33.5B |
| ILMNIllumina | $40.7B |
| GEHCGE HealthCare Technologies | $32.3B |
| ONCBeOne Medicines | $42.9B |
| IDXXIDEXX Laboratories | $44.1B |
| WATWaters | $44.6B |
| Peer median | $36.8B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Royalty Pharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.